Source: Annual Congress 2013 –ERS/JAMA Lunchtime session "Advances in IPF, bronchiectasis and sarcoidosis"



Rating:

Share or cite this content

Citations should be made in the following way:
J.S. Elborn (Belfast, United Kingdom). Long-term macrolide therapy for non-CF bronchiectasis. Annual Congress 2013 –ERS/JAMA Lunchtime session "Advances in IPF, bronchiectasis and sarcoidosis"

Member's Comments

No comment yet.

Related content which might interest you: Aerozolized colistin therapy in non-cystic fibrosis patients with bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 266s Year: 2001 Effects of long-term azithromycin treatment in patients with non-cystic fibrosis stable bronchiectasis Source: Annual Congress 2007 - Infectious lung and pleural diseases Year: 2007 Immunomodulative therapy in young patients with non-CF bronchiectases exacerbations Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood Year: 2009 Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics? Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections Year: 2016 Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Resistance to antimicrobial agents in patients with non-cystic fibrosis (CF) bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 640s Year: 2005 The low dose macrolides for prevention of exacerbations in non-CF bronchiectasis Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 Long-term administration of aerosolised tobramycin in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 619s Year: 2005 Effectiveness of inhaled colistin by iNeb® device in non-CF bronchiectasis and chronic pseudomonas infection Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 Azithromycin, a novel maintenance therapy in patients with chronic non-CF suppurative lung disease Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Prognostic indicators of adult patients with non-CF bronchiectasis and those with combined COPD and non-CF bronchiectasis Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Long-term macrolide therapy in chronic inflammatory airway diseases Source: Eur Respir J 2009; 33: 171-181 Year: 2009 Efficacy of macrolide and thymus peptide in the management of bronchiectasis Source: Eur Respir J 2005; 26: Suppl. 49, 641s Year: 2005 The clinical impact of nebulised antibiotics in adults with bronchiectasis and chronic pseudomonas aeruginosa Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis Source: Eur Respir J, 54 (1) 1801896; 10.1183/13993003.01896-2018 Year: 2019 Inhaled colistin following lung transplantation in colonised cystic fibrosis patients Source: Eur Respir J 2013; 42: 542-544 Year: 2013 Inhaled steroids in children with non-cystic fibrosis bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 392s Year: 2004 Eradication treatment in Non CF bronchiectasis: The effect of inhaled antibiotics (tobramycin and colistin) on patients with pseudomonas aeruginosa Source: International Congress 2017 – Clinical update on bronchiectasis and nontuberculous mycobacteria (NTM) infections Year: 2017 Factors associated with the need of intravenous antibiotics in a cohort of adult patients with non-CF bronchiectasis Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Survey of microbiology, pseudomonas eradication and antimicrobial prophylaxis in adult patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011